HCA Healthcare Inc
NYSE:HCA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nyxoah SA
XBRU:NYXH
|
BE |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (11.9), the stock would be worth $461.49 (2% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 12.2 | $471.34 |
0%
|
| 3-Year Average | 11.9 | $461.49 |
-2%
|
| 5-Year Average | 11.5 | $443.41 |
-6%
|
| Industry Average | 19.2 | $743.81 |
+58%
|
| Country Average | 19.6 | $758.23 |
+61%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
$160.6B
|
/ |
Jan 2026
$12B
|
= |
|
|
$160.6B
|
/ |
Dec 2026
$12.5B
|
= |
|
|
$160.6B
|
/ |
Dec 2027
$13B
|
= |
|
|
$160.6B
|
/ |
Dec 2028
$13.7B
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
107.6B USD | 12.2 | 15.9 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 40 | 40.8 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
24B ZAR | 9.5 | 14.3 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
77.8B MYR | 22.8 | 37.1 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
18B ZAR | -53.4 | 4.7 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
87B BRL | 9.4 | 18.6 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
16.6B USD | 7.1 | 11.8 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
91.9B CNY | 20.3 | 28.6 | |
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 42.7 | 61 | |
| US |
|
Ensign Group Inc
NASDAQ:ENSG
|
10.8B USD | 24.1 | 31.1 | |
| US |
|
Universal Health Services Inc
NYSE:UHS
|
11B USD | 7.5 | 7.4 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.6 |
| Median | 19.6 |
| 70th Percentile | 27.8 |
| Max | 1 826 183.2 |
Other Multiples
HCA Healthcare Inc
Glance View
HCA Healthcare Inc., a titan in the American healthcare landscape, traces its origins back to 1968 when Dr. Thomas F. Frist Sr., his son Dr. Thomas F. Frist Jr., and businessman Jack C. Massey founded the company with a vision to provide quality care in hospital settings. Fast forward to today, HCA operates an extensive network of 182 hospitals and over 2,300 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers, and physician clinics, spreading its healthcare prowess across 20 U.S. states and the United Kingdom. At the core of its operations is a robust infrastructure dedicated to delivering comprehensive medical services ranging from basic emergency care to intricate surgical procedures and specialized treatments. This strategic breadth allows HCA to harness economies of scale, enhancing operational efficiency and improving patient outcomes. The financial engine fueling HCA Healthcare is multifaceted, driven primarily by patient services revenues. This encompasses everything from inpatient care, outpatient services, and ancillary services like laboratories and imaging. Such diverse offerings not only boost the company's revenue streams but also position it to adapt to evolving healthcare needs and regulatory changes. By continuously investing in state-of-the-art medical technology and adopting innovative care models, HCA enhances its service quality and patient retention, which results in stabilized financial performance. With a focus on both urban and suburban communities, HCA leverages its clinical expertise and geographic reach to capture significant market share, fostering a sustainable and profitable business model that underscores its stature as a leader in the healthcare sector.